The expert faculty analyze the recently presented ALBAN trial, a phase 3 study evaluating atezolizumab in combination with intravesical BCG versus BCG alone for BCG-naïve, high-risk non–muscle ...

Do you often replay the bad yet always forget the good? Here’s the science behind negative thought spirals and how to find balance and resilience. Do you know why our brains can replay our most ...

Triple-negative breast cancer lacks key receptors, requiring chemotherapy, immunotherapy, surgery, and radiation, with treatment tailored to cancer stage. Early-stage TNBC treatment often involves ...

Abstract: Recently, Few-Shot Object Detection (FSOD) has received considerable research attention as a strategy for reducing reliance on extensively labeled bounding boxes. However, current approaches ...

Last month, North American patriotism was tested, when WWE Chief Content Officer Paul "Triple H" Levesque announced that for the first-time in company history, its annual springtime show, WrestleMania ...

When a new UI or UX feature lands poorly, the consequences for a SaaS company can be immediate and often very public: customer frustration, reduced trust and even a dip in sales or retention. While ...

“See, this day I set before you blessing and curse: blessing, if you obey the commandments of your God that I enjoin upon you this day; and curse, if you do not obey the commandments of your God.” ...

Preferred shares are an income investor’s best friend when it comes to hybrid securities, which sit above common equity in the capital structure. When a preferred share is trading above its call price ...